12,210
-0.81%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About I Sens
Its shares trade on KOSDAQ under the ticker 099190.KQ. It has been listed since 30 January 2013. In the fiscal year to 31 December 2025, it reported revenue of ₩315.44bn and a net loss of ₩5.15bn. At that date it held total assets of ₩577.66bn and shareholders' equity of ₩315.25bn.
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 30 Jan 2013
- Website
- i-sens.co.kr ↗
Leadership
Pay as last reported
- Mr. Geun Sik ChaChief Executive Officer, Director
- Hak Hyeon NamVice President, Director
- Ja Su LeeVice President
- Yong Sang KimAssistant Managing Director
- DR. Yeong Chul SongInternal Auditor
- Gang Se LeeDirector
- Gi Jeong PaengNon-Executive Independent Director
- Pakr StevenNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- CareSens blood glucose monitors are widely used in South Korea for diabetes management.
- I Sens Inc. has a strong presence in Japan and European markets with its glucose monitoring systems.
- The company's electrolyte analyzers and cartridges are key products in the medical sector.
Weaknesses
- I Sens Inc. relies heavily on the domestic South Korean market for revenue generation.
- The company's product range is limited to medical sensors without diversification into other sectors.
- I Sens Inc. has no presence in the United States market despite targeting it.
Opportunities
- Expanding into the U.S. market could significantly increase I Sens Inc.'s global reach.
- Growing demand for diabetes management systems presents a major opportunity for the company.
- International expansion into new regions can leverage existing product strengths.
Threats
- Competition from established medical sensor companies in Europe and Japan poses a threat.
- Regulatory changes in the Health Care sector could impact product approvals.
- Economic downturns in key markets may reduce demand for medical devices.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.